Japan has developed a new method for detecting cancer

Japan, "Asahi Shimbun" reported that recently, the research team of Japan National Cancer Research Center announced that it has developed a new research method for detecting cancer. Using this method, you only need a small amount of blood samples, it is possible to comprehensively on 60 kinds of genetic material associated with cancer comprehensive testing.

Prior to this, if you want to perform the same comprehensive testing, cancer patients often need to extract parts of the organization to carry out testing. The new detection method can avoid increasing the burden on the premise of the patient's body, repeated constantly on the degree of progress of cancer patients were detected, according to test results and thus able to select the corresponding drug.

Due to the latest research results have demonstrated that although associated with the different types of breast cancer, lung cancer and other genetic material unusual circumstances are not the same, but there are some exceptions genetic material is all kinds of cancer are common. Thus, in a particular abnormal genetic material anticancer drugs that target, if for a particular type of cancer produce a therapeutic effect, it is possible also to other types of cancer have a role. However, to fully enlist cancer-related genetic material abnormality comprehensive testing, it must be extracted cancerous tissue puncture site by other methods.

To this end, the research team of Japan National Cancer Research Center focuses on penetration from the cancerous tissue into the patient's blood is extremely small amounts of DNA, using the most advanced analytical equipment, blood for 48 pancreatic cancer patients from the cancerous tissue penetration carried out DNA detection. Through continuous improvement of the analytical method for the detection of data, the research team in each patient 5 ml blood, are correctly detected 60 kinds of abnormal genetic material. In this regard, research project leader, he said, since it has been confirmed that the new detection method is suitable for pancreatic cancer, then it should also be applied to all types of cancer.